Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Life Science
Date founded
2021
Funding rounds raised
Total raised
$155M
from 16 investors over 16 rounds
A
ArriVent Biopharma raised $155M on December 29, 2022
Investors: Octagon Capital Advisors, Lilly Asia Ventures, Sofinnova Ventures, Russia technology fund, Sirona Capital, Sequoia Capital China and Unicorn Capital Partners 獨秀資本
A
ArriVent Biopharma raised $69M on February 15, 2022
Investors: Lilly Asia Ventures, Octagon Capital Advisors, Hillhouse Capital Management, OrbiMed Advisors and Boyu Capital
A
ArriVent Biopharma raised $81M on June 30, 2021
Investors: Lilly Asia Ventures, Octagon Capital Advisors, Boyu Capital, Hillhouse Capital Management and OrbiMed Advisors